Pennsylvania Medicaid Ends Coverage for Obesity Medications | Retatrutide News

Pennsylvania has cut Medicaid coverage for obesity drugs, affecting many patients. This could impact access to GLP-1 agonists like Retatrutide.
Market News · October 21, 2026